Description: This three-part series provides an overview of the rapidly evolving and dynamic gene and cellular therapy landscape, from the clinical, historical, and risk transfer perspectives. It covers the actuarial considerations in pricing cell and gene insurance and reinsurance, the value assessment of the therapies, manufacturer pricing, and reinsurance cost.

Description: This three-part series provides an overview of the rapidly evolving and dynamic gene and cellular therapy landscape, from the clinical, historical, and risk transfer perspectives. It covers the actuarial considerations in pricing cell and gene insurance and reinsurance, the value assessment of the therapies, manufacturer pricing, and reinsurance cost.

Description: For this session, we will explore difference in Medicare products from Traditional Medicare to Medicare Advantage. It will clarify different parts of the benefits and the role of Medigap plans. We will then discuss the impending changes in Medicare Part D due to the Inflation Reduction Act, highlighting redesigned benefits, stakeholder impacts, & potential risks. This informative session aims to demystify Medicare, providing insights into existing structures and forthcoming alterations.